These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 14762439

  • 1. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H, Otsuka M, Tateishi K, Ikenoue T, Kawakami T, Kanai F, Arakawa Y, Seki N, Shimizu K, Miyazono K, Kawabe T, Omata M.
    Oncogene; 2004 Feb 05; 23(5):1043-51. PubMed ID: 14762439
    [Abstract] [Full Text] [Related]

  • 2. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ.
    Clin Cancer Res; 2002 Nov 05; 8(11):3628-38. PubMed ID: 12429655
    [Abstract] [Full Text] [Related]

  • 3. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, Ohta M, Imamura J, Tanaka Y, Tateishi K, Ikenoue T, Kawakami T, Arakawa Y, Miyagishi M, Taira K, Kawabe T, Omata M.
    Oncogene; 2005 Jan 20; 24(4):662-71. PubMed ID: 15592526
    [Abstract] [Full Text] [Related]

  • 4. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP, Mikkola D, Willson JK, Markowitz S.
    Oncogene; 2003 Mar 06; 22(9):1317-23. PubMed ID: 12618756
    [Abstract] [Full Text] [Related]

  • 5. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L, Hill CS.
    Mol Cell Biol; 2005 Sep 06; 25(18):8108-25. PubMed ID: 16135802
    [Abstract] [Full Text] [Related]

  • 6. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
    Hummer BT, Bartlett C, Henry E, Weissman BE.
    J Cell Physiol; 2003 Mar 06; 194(3):289-302. PubMed ID: 12548549
    [Abstract] [Full Text] [Related]

  • 7. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 8. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N, Perrais M, Mariette C, Batra SK, Aubert JP, Pigny P, Van Seuningen I.
    Oncogene; 2004 Jul 29; 23(34):5729-38. PubMed ID: 15184872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, Tararak E, Bobik A.
    Arterioscler Thromb Vasc Biol; 2004 Aug 29; 24(8):1391-6. PubMed ID: 15166010
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism.
    Schiller M, Verrecchia F, Mauviel A.
    Oncogene; 2003 Dec 04; 22(55):8881-90. PubMed ID: 14654784
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
    Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J.
    J Cell Physiol; 2000 Jun 04; 183(3):381-92. PubMed ID: 10797313
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Büchler MW, Falb D, Korc M.
    Oncogene; 1999 Sep 23; 18(39):5363-72. PubMed ID: 10498890
    [Abstract] [Full Text] [Related]

  • 20. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.